{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-063396","form_type":"8-K","ticker":"COLL","cik":"0001267565","company_name":"COLLEGIUM PHARMACEUTICAL, INC","filed_at":"2024-05-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.656536+00:00","generated_at":"2026-06-01T12:22:12.335118+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Collegium shareholders re-elect all eight directors and approve say-on-pay at 2024 annual meeting","bullets":["All eight director nominees re-elected; each received >98% of votes cast (For range: 25.4M-28.4M).","Advisory vote on executive compensation passed with 28,311,783 For (98.8% of votes cast).","Ratification of Deloitte & Touche as independent auditor for FY2024 approved with 30,106,217 For.","Annual meeting held May 16, 2024; 31,059,529 shares present (94.9% of outstanding shares).","Broker non-votes were 2,360,841 on director and say-on-pay; 837,061 on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-063396","json":"https://secwatch.observer/filing/0001104659-24-063396.json","markdown":"https://secwatch.observer/filing/0001104659-24-063396.md","text":"https://secwatch.observer/filing/0001104659-24-063396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267565/000110465924063396/0001104659-24-063396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267565/000110465924063396/tm2414882d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T12:22:12.335118+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}